603718 Stock Overview
Researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Shanghai Hile Bio-Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.18 |
| 52 Week High | CN¥11.38 |
| 52 Week Low | CN¥5.74 |
| Beta | 1.04 |
| 11 Month Change | 10.69% |
| 3 Month Change | 22.82% |
| 1 Year Change | -27.29% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603718 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.2% | 3.7% | 2.3% |
| 1Y | -27.3% | -5.7% | 5.6% |
Return vs Industry: 603718 underperformed the CN Pharmaceuticals industry which returned -7% over the past year.
Return vs Market: 603718 underperformed the CN Market which returned 4.2% over the past year.
Price Volatility
| 603718 volatility | |
|---|---|
| 603718 Average Weekly Movement | 8.2% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603718 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603718's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 295 | n/a | www.hile-bio.com |
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines.
Shanghai Hile Bio-Technology Co., Ltd. Fundamentals Summary
| 603718 fundamental statistics | |
|---|---|
| Market cap | CN¥5.38b |
| Earnings (TTM) | CN¥8.35m |
| Revenue (TTM) | CN¥220.55m |
644.9x
P/E Ratio24.4x
P/S RatioIs 603718 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603718 income statement (TTM) | |
|---|---|
| Revenue | CN¥220.55m |
| Cost of Revenue | CN¥113.48m |
| Gross Profit | CN¥107.07m |
| Other Expenses | CN¥98.72m |
| Earnings | CN¥8.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.013 |
| Gross Margin | 48.55% |
| Net Profit Margin | 3.78% |
| Debt/Equity Ratio | 5.0% |
How did 603718 perform over the long term?
See historical performance and comparison